9/21/2010

GlaxoSmithKline is putting into review its U.S. media planning and buying account, for which spending is $1.4 billion. Incumbent WPP Group's MediaCom reportedly will participate in the review, which will cover pharma and consumer health care. The shop recently was successful in defending GSK's U.K. media account.

Related Summaries